Literature DB >> 1400863

Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men.

N Orentreich1, J L Brind, J H Vogelman, R Andres, H Baldwin.   

Abstract

Dehydroepiandrosterone sulfate (DS) was measured by direct tritium RIA in longitudinal plasma specimens from 97 normal healthy male participants in the Baltimore Longitudinal Study of Aging. Fasting blood was collected at regular visits (approximately 1.5 yr apart) over an average 13 yr of adulthood (cumulative age range: 32-83 yr). DS was measured in 3-4 widely spaced specimens from each subject. A decline in DS was found in 65 (67%) subjects, 13 subjects (13%) showed no change, and increases were found in the 19 remaining subjects during the study period. A plot of individual data points revealed the same pattern we had obtained previously from a cross-sectional study of a different normal male population. A plot of DS values vs. age among subjects whose DS increased during the study also revealed an age-related decline. Thus, the longitudinal decrease in circulating DS, long inferred from cross-sectional data, is confirmed for normal men in the present study. A more detailed study of every specimen collected during the study period from 12 of the Baltimore Longitudinal Study of Aging subjects (4 whose values tended to be low, 4 whose values tended to be high, and 4 whose values were near the mean) failed to reveal any patterns of variation that could be correlated with changes in life circumstances, health status, or any other discernible factors. Hence, the wide variability seen in DS among individuals within normal populations remains unexplained.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400863     DOI: 10.1210/jcem.75.4.1400863

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  77 in total

Review 1.  Dehydroepiandrosterone sulfate and longevity: new clues for an old friend.

Authors:  S S Yen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

2.  Administration of dehydroepiandrosterone (DHEA) enhances visual-spatial performance in postmenopausal women.

Authors:  Bethany Stangl; Elliot Hirshman; Joseph Verbalis
Journal:  Behav Neurosci       Date:  2011-10       Impact factor: 1.912

3.  Effect of lithium maintenance treatment on hypothalamic pituitary gonadal axis in bipolar men.

Authors:  M Kusalic; F Engelsmann
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

4.  Dehydroepiandrosterone sulfate and bone resorption rates as reflected by serum levels of C-terminal telopeptide of type I collagen: a study in healthy men.

Authors:  V Carnevale; A Scillitani; E Vecci; E D'Erasmo; E Romagnoli; F Paglia; J Pepe; V Baldini; C Santori; S De Geronimo; S Minisola
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

5.  Dehydroepiandrosterone and human adipose tissue.

Authors:  F Saraç; S Yildiz; F Saygili; G Ozgen; C Yilmaz; T Kabalak; M Tüzün
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 6.  Neuroendocrine effects of stress on immunity in the elderly: implications for inflammatory disease.

Authors:  Kathi L Heffner
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

Review 7.  Hormonal regulation of longevity in mammals.

Authors:  Holly M Brown-Borg
Journal:  Ageing Res Rev       Date:  2007-02-20       Impact factor: 10.895

Review 8.  [Hormone therapy and anti-aging: is there an indication?].

Authors:  D Heutling; H Lehnert
Journal:  Internist (Berl)       Date:  2008-05       Impact factor: 0.743

9.  Fatty acid metabolism in the elderly: effects of dehydroepiandrosterone and testosterone replacement in hormonally deficient men and women.

Authors:  Christina Koutsari; Asem H Ali; K Sreekumaran Nair; Robert A Rizza; Peter O'Brien; Sundeep Khosla; Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

Review 10.  Androgen therapy with dehydroepiandrosterone.

Authors:  Jacques Buvat
Journal:  World J Urol       Date:  2003-10-10       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.